Institutional investors purchased a net $1.6 million shares of CYTR during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 37.65% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HIGHMARK CAPITAL MANAGEMENT, INC... Sold 65.4 Thousand shares of CytRx Corp